2-(cyclohexylmethyl)thiophene | 82145-72-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 杂芳族化合物
• 英文名称: 2-(cyclohexylmethyl)thiophene
• 英文别名: Cyclohexylmethylthiophene
• CAS: 82145-72-0
• 化学式: C₁₁H₁₆S
• 分子量: 180.314
• InChiKey: SEZATVDVNWUSBZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  28.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-(cyclohexylmethyl)thiophene 生成 isonicotinic acid-[(5-cyclohexylmethyl-[2]thienylmethylene)-hydrazide]
  参考文献：
  名称：

  Buu-Hoi et al., Journal of the Chemical Society, 1955, p. 1581,1583

  摘要：

  DOI：
• 作为产物：
  描述：

  环己基(噻吩-2-基)甲酮 生成 2-(cyclohexylmethyl)thiophene
  参考文献：
  名称：

  Buu-Hoi et al., Journal of the Chemical Society, 1955, p. 1581,1583

  摘要：

  DOI：

文献信息

• Nickel-Catalyzed Cross-Coupling of Umpolung Carbonyls and Alkyl Halides
  作者：Dianhu Zhu、Leiyang Lv、Zihang Qiu、Chao-Jun Li

  DOI：10.1021/acs.joc.9b00649

  日期：2019.5.17

  nickel-catalyzed cross-coupling of Umpolung carbonyls and alkyl halides was developed. Complementary to classical alkylation techniques, this reaction utilizes Umpolung carbonyls as the environmentally benign alkyl nucleophiles, providing an efficient and selective catalytic alternative to the traditional use of highly reactive alkyl organometallic reagents.

  开发了有效的镍催化的Umpolung羰基化合物与烷基卤化物的交叉偶联。作为经典烷基化技术的补充，该反应利用Umpolung羰基化合物作为对环境无害的烷基亲核试剂，为传统的高反应性烷基有机金属试剂的使用提供了有效和选择性的催化替代方法。
• [EN] ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME<br/>[FR] COMPOSÉ IMIDATE À INSATURATION ?, ? ET COMPOSITION PESTICIDE LE CONTENANT
  申请人：SUMITOMO CHEMICAL CO

  公开号：WO2009064031A1

  公开（公告）日：2009-05-22

  There is provided a compound having an excellent controlling effect on pests, represented by the formula (I): wherein, A and E independently represent a -R1 group, a -L1-R1 group, etc.; G represents a -L2-R1 group, a -S(O)2-R4 group, etc.; X represents a -S-R5 group or a -O-R6 group; Z represents an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; R1 represents an optionally substituted C1-C20 chain hydrocarbon group, etc.; R5 represents a substituted C1-C4 alkyl group, an optionally substituted C5-C10 alkyl group, etc.; R6 represents a substituted C1-C2 alkyl group, an optionally substituted C3-C10 alkyl group, etc.; L1 represents a an oxygen atom, a sulfur atom, a -S(O)- group, or a -S(O)2- group; and L2 represents an oxygen atom or a sulfur atom.

  提供一种在害虫上具有优异控制效果的化合物，其表示为以下结构式（I）：其中，A和E分别代表一个-R1基团，一个-L1-R1基团等；G代表一个-L2-R1基团，一个-S(O)2-R4基团等；X代表一个-S-R5基团或一个-O-R6基团；Z代表一个可选择取代的碳环基团或一个可选择取代的杂环基团；R1代表一个可选择取代的C1-C20链烃基团等；R5代表一个取代的C1-C4烷基基团，一个可选择取代的C5-C10烷基基团等；R6代表一个取代的C1-C2烷基基团，一个可选择取代的C3-C10烷基基团等；L1代表一个氧原子，一个硫原子，一个-S(O)-基团，或一个-S(O)2-基团；L2代表一个氧原子或一个硫原子。
• 4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES USEFUL AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-1 (DPP-1)
  申请人：DeCorte Bart L.

  公开号：US20110224209A1

  公开（公告）日：2011-09-15

  The present invention is directed to 4,4-di-substituted piperidine derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by DPP-1.

  本发明涉及4,4-二取代哌啶衍生物，含有它们的药物组合物以及它们在治疗由DPP-1调节的疾病和症状中的应用。
• Facile deprotection of Fmoc protected amino groups
  申请人：——

  公开号：US20020058788A1

  公开（公告）日：2002-05-16

  The present invention provides a method for deprotecting a Fmoc protected amino group, said method comprising treating in a suitable medium the protected amino group with a base in the presence of a thiol compound to yield a deprotected amino group.

  本发明提供了一种去保护Fmoc保护氨基的方法，该方法包括在适当介质中，在硫醇化合物的存在下，用碱处理保护氨基，以产生去保护的氨基。
• Indolinone combinatorial libraries and related products and methods for the treatment of disease
  申请人：Tang Cho Peng

  公开号：US20050197382A1

  公开（公告）日：2005-09-08

  The present invention relates to organic molecules capable of modulating, regulating and/or inhibiting protein kinase signal transduction. Such compounds are useful for the treatment of diseases related to unregulated protein kinase signal transduction, including cell proliferative diseases such as cancer, atherosclerosis, arthritis and restenosis and metabolic diseases such as diabetes. The present invention features indolinone compounds that potently inhibit protein kinases and related products and methods. Inhibitors specific to the FLK protein kinase can be obtained by adding chemical substituents to the 3-[(indole-3-yl)methylene]-2-indolinone, in particular at the 1′ position of the indole ring. Indolinone compounds that specifically inhibit the FLK and platelet derived growth factor protein kinases can harbor a tetrahydroindole or cyclopentano-b-pyrrol moiety. Indolinone compounds that are modified with substituents, particularly at the 5 position of the oxindole ring, can effectively activate protein kinases. This invention also features novel hydrosoluble indolinone compounds that are tyrosine kinase inhibitors and related products and methods.

  本发明涉及有机分子，能够调节、调控和/或抑制蛋白激酶信号转导。这些化合物对于治疗与不受调节的蛋白激酶信号转导相关的疾病非常有用，包括细胞增殖性疾病，如癌症、动脉粥样硬化、关节炎、再狭窄和代谢性疾病，如糖尿病。本发明涉及具有强效抑制蛋白激酶和相关产品以及方法的吲哚酮化合物。特定于FLK蛋白激酶的抑制剂可以通过在吲哚环的1'位置添加化学取代基来获得3-[(吲哚-3-基)亚甲基]-2-吲哚酮。特异性抑制FLK和血小板衍生生长因子蛋白激酶的吲哚酮化合物可以具有四氢吲哚或环戊烯基-β-吡咯基。在氧吲哚环的5位取代基的修饰下，吲哚酮化合物可以有效激活蛋白激酶。本发明还涉及新型水溶性吲哚酮化合物，它们是酪氨酸激酶抑制剂和相关产品和方法。